Tsuruha Holdings Inc. (TSUSF) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Tsuruha Holdings Inc. (TSUSF) Healthcare & Pipeline Overview

Tsuruha Holdings Inc. is a prominent player in Japan's pharmaceutical retail market, operating over 2,400 stores and offering a diverse range of products, including pharmaceuticals and cosmetics, with a focus on customer service and accessibility.

What Is the Investment Thesis for TSUSF?

Tsuruha Holdings Inc. is positioned for continued growth in the Japanese pharmaceutical retail market, supported by a market capitalization of $4.20B and a P/E ratio of 21.5. The company benefits from a solid profit margin of 2.9% and a gross margin of 30.6%, indicating efficient operations. Key growth catalysts include the expansion of its store network, particularly in urban areas, and the increasing consumer demand for health and wellness products. The company's dividend yield of 2.36% also reflects its commitment to returning value to shareholders. However, potential risks include regulatory changes in the pharmaceutical industry and competition from other retail drugstores, which could impact profitability and market share.

Based on FMP financials and quantitative analysis

TSUSF Key Highlights

Market Cap of $4.20B indicates a strong market presence in the pharmaceutical sector.

• P/E ratio of 21.5 suggests a premium valuation relative to earnings.
• Profit margin of 2.9% reflects operational efficiency in the retail space.
• Gross margin of 30.6% exceeds industry averages, indicating strong pricing power.
• Dividend yield of 2.36% demonstrates the company's commitment to shareholder returns.

Who Are TSUSF's Competitors?

TSUSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TSUSF's Key Strengths?

Strong market presence with over 2,400 stores.

• Diverse product offerings in pharmaceuticals and cosmetics.
• Established brand loyalty among consumers.
• Efficient operational management reflected in profit margins.

What Are TSUSF's Weaknesses?

Dependence on the Japanese market for revenue.

• Relatively low profit margins compared to some competitors.
• Limited international presence outside of Thailand.
• Potential vulnerability to regulatory changes in the pharmaceutical sector.

What Could Drive TSUSF Stock Higher?

Expansion of store network in urban areas over the next three years.

• Investment in e-commerce to enhance online sales capabilities.
• Diversification of product offerings to include organic and natural health products.
• Strategic partnerships with healthcare providers to improve service offerings.
• Targeted marketing campaigns to attract health-conscious consumers.

What Are the Key Risks for TSUSF?

Regulatory changes impacting pharmaceutical sales and operations.

• Intense competition from established drugstore chains.
• Economic downturns affecting consumer spending on healthcare products.
• Shifts in consumer preferences towards online shopping and e-commerce.

What Are the Growth Opportunities for TSUSF?

• Expansion of Store Network: Tsuruha Holdings plans to increase its store count in urban areas, targeting a 10% growth in locations over the next three years. This expansion is expected to enhance accessibility for customers and drive sales growth, capitalizing on the increasing demand for convenience in healthcare.
• E-commerce Development: The company is investing in its online sales platform to capture the growing trend of e-commerce in the healthcare sector. With the e-commerce market for pharmaceuticals projected to reach $10 billion in Japan by 2028, Tsuruha's digital strategy aims to tap into this lucrative segment.
• Product Diversification: Tsuruha is focusing on expanding its product range to include more health and wellness items, including organic and natural products. This diversification is expected to attract a broader customer base, especially among health-conscious consumers, and drive revenue growth.
• Strategic Partnerships: The company is exploring partnerships with healthcare providers and wellness brands to enhance its service offerings. Collaborations in health services could lead to increased foot traffic and sales, as well as improved customer loyalty.
• International Expansion: With 22 stores in Thailand, Tsuruha Holdings is looking to further penetrate Southeast Asian markets. The region's growing middle class and increasing health awareness present significant opportunities for growth, potentially doubling its international footprint in the next five years.

What Are TSUSF's Competitive Advantages?

• Established brand reputation in the Japanese healthcare market.
• Extensive store network providing convenience and accessibility.
• Strong customer loyalty driven by quality service and product offerings.
• Diverse product range catering to various consumer needs.
• Experience and expertise in navigating regulatory environments.

What Does TSUSF Do?

Founded in 1929, Tsuruha Holdings Inc. has established itself as a significant player in the Japanese healthcare sector, particularly in the retail of pharmaceuticals and cosmetics. Headquartered in Sapporo, Japan, the company has expanded its operations to include 2,448 drugstores across Japan and 22 additional stores in Thailand as of October 15, 2021. The company's retail strategy focuses on providing a wide range of products, including over-the-counter medications, prescription drugs, and beauty products, catering to the diverse needs of its customers. Tsuruha Holdings has built a reputation for quality and customer service, which has allowed it to maintain a competitive edge in a market characterized by increasing demand for health and wellness products. Over the years, the company has adapted to changing consumer preferences, emphasizing the importance of convenience and accessibility in its store locations. As the healthcare landscape evolves, Tsuruha Holdings continues to explore opportunities for growth and expansion, aiming to enhance its market position while maintaining its commitment to customer satisfaction.

What Products and Services Does TSUSF Offer?

• Operate a network of drugstores in Japan and Thailand.
• Sell a wide range of pharmaceutical products, including prescription and over-the-counter medications.
• Offer cosmetic and personal care products to meet diverse consumer needs.
• Focus on customer service and convenience in store locations.
• Adapt to changing consumer preferences in health and wellness.
• Engage in community health initiatives to enhance brand reputation.

How Does TSUSF Make Money?

• Generate revenue through the sale of pharmaceuticals and cosmetics.
• Leverage a large store network to increase customer accessibility.
• Utilize a customer-centric approach to enhance loyalty and repeat business.
• Expand product offerings to capture a wider market share.
• Invest in e-commerce to complement physical store sales.

What Industry Does TSUSF Operate In?

The pharmaceutical retail industry in Japan is characterized by a growing demand for health and wellness products, driven by an aging population and increasing health consciousness among consumers. The market is expected to continue expanding, with a projected growth rate of approximately 3% annually over the next five years. Tsuruha Holdings Inc. operates in a competitive landscape, facing rivals such as Matsumotokiyoshi Holdings Co., Ltd. and Welcia Holdings Co., Ltd. These competitors also focus on expanding their store networks and enhancing product offerings to capture market share. Tsuruha's strategic positioning and established brand reputation provide it with a competitive advantage in this evolving market.

Who Are TSUSF's Key Customers?

• General consumers seeking pharmaceutical and cosmetic products.
• Health-conscious individuals looking for wellness solutions.
• Elderly customers requiring prescription medications.
• Families purchasing over-the-counter health products.
• Young adults interested in beauty and personal care items.

Tsuruha Holdings Inc. Financial Trajectory

Tsuruha Holdings Inc. (TSUSF) reported $637.51B in revenue for Q2 2026, reflecting 3.0% growth compared to the prior quarter. The company recorded net income of $13.49B, with diluted EPS of $30.30. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, TSUSF averaged $32.44 in diluted EPS.

Company Profile

Tsuruha Holdings Inc. operates in the Specialty Retail industry within the Consumer Cyclical sector. It is headquartered in Sapporo, JP. The company is led by CEO Jun Tsuruha. TSUSF has traded publicly since 2014.

How Tsuruha Holdings Inc. Is Valued

Tsuruha Holdings Inc. carries a market capitalization of $4.20B, placing it in the mid-cap category. Relative to its peer group, TSUSF's quantitative score of 49/100 is roughly in line with the peer average of 50/100.

Return on equity for Tsuruha Holdings Inc. stands at 7.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.7%, showing how much profit it generates from its asset base. TSUSF trades at a trailing price-to-earnings ratio of 21.45, roughly in line with the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.29 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.2%, the inverse of the P/E and a quick read on earnings relative to price.

Tsuruha Holdings Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.06 places it in the grey zone, a middle ground that warrants monitoring.

Tsuruha Holdings Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 4.8% above estimates on average.

Wall Street analysts project Tsuruha Holdings Inc. revenue of about $2.59T for fiscal 2027, with EPS near $103.72. The estimate reflects 8 contributing analysts.

TSUSF Financials

TSUSF Latest News

No recent news available for TSUSF.

TSUSF Analyst Consensus

TSUSF MoonshotScore

Tsuruha Holdings Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources